Ibuki Naokazu 伊夫貴直和

Researcher Number	90368100
Other IDs
Affiliation (based on the past Project Information) *help	2018 – 2020: 大阪医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related
Keywords	Principal Investigator Hedgehog pathway / Hedgehog / Enzalutamide / 去勢抵抗性前立腺癌

Elucidation of castration-resistant prostate cancer mechanism via hedgehog pathwayPrincipal Investigator
- Principal Investigator
  
  Ibuki Naokazu
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Osaka Medical College

All 2019 2018

All Journal Article Presentation

[Journal Article] The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.2019
- Author(s)
  Komura K,Hashimoto T, Tsujino T, Muraoka R, Tsutsumi T, Satake N, Matsunaga T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Uehara H, Tanaka T, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.
- Journal Title
  
  Ann Surg Oncol.
  
  Volume: 26(9) Issue: 9 Pages: 2994-3004
- DOI
  10.1245/s10434-019-07530-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-18K16716
[Journal Article] Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.2019
- Author(s)
  Komura　K,Fujiwara Y,UchimotoT,Saito K,Tanda N,Matsunaga T, Ichihashi A,Tsutsumi T, Tsujino T,Yoshikawa Y,Nishimoto Y,Takai T,Minami K,Taniguchi K,Tanaka T, Uehara H,Hirano H,Nomi H,Ibuki N, Takahara K,Inamoto T,Azuma H.
- Journal Title
  
  J. Clin. Med.
  
  Volume: 8(8) Issue: 8 Pages: 1251-1251
- DOI
  10.3390/jcm8081251
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-18K16716
[Journal Article] hibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.2018
- Author(s)
  Komura K、Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW.
- Journal Title
  
  Journal of Clinical Investigation
  
  Volume: 128(7) Issue: 7 Pages: 2979-95
- DOI
  10.1172/jci96769
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11033, KAKENHI-PROJECT-18K16716, KAKENHI-PUBLICLY-18H04798, KAKENHI-PROJECT-15H05325, KAKENHI-PROJECT-17K16821
[Journal Article] A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder2018
- Author(s)
  Inamoto Teruo、Uehara Hirofumi、Akao Yukihiro、Ibuki Naokazu、Komura Kazumasa、Takahara Kiyoshi、Takai Tomoaki、Uchimoto Taizo、Saito Kenkichi、Tanda Naoki、Yoshikawa Yuki、Minami Koichiro、Hirano Hajime、Nomi Hayahito、Kato Ryuji、Hayashi Tetsuya、Azuma Haruhito
- Journal Title
  
  Disease Markers
  
  Volume: 2018 Pages: 1-6
- DOI
  10.1155/2018/5468672
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10611, KAKENHI-PROJECT-18K16716, KAKENHI-PROJECT-17K16821
[Presentation] 生体腎移植前のドナー検査において腫瘍性病変が指摘され、根治的治療が可能であった3症例2019
- Author(s)
  上原博史、平野一、岡部知太、木村孝平、寺本昌司、高倉一平、西村一希、木下将宏、徳永雄希、中森啓太、市橋淳、谷口俊理、小林大介、堤岳之、小村和正、伊夫貴直和、稲元輝生、能見勇人、東治人.
- Organizer
  第53回日本臨床腎移植学会
- Data Source
  KAKENHI-PROJECT-18K16716
[Presentation] ハイリスクホルモン感受性転移性前立腺癌に対するAbiraterone acetateとPrednisolone併用療法の治療効果2019
- Author(s)
  伊夫貴　直和、稲元輝生、西本優大、内本泰三、光野絢子、藤川正弘、土井　亘、宮下　由紀恵、木村亮輔、小山耕平、木山　賢、和辻利和、東　治人.
- Organizer
  第69回日本泌尿器科学会中部総会
- Data Source
  KAKENHI-PROJECT-18K16716
[Presentation] Treatment outcome of dose reduction of enzalutamide against CRPC?2019
- Author(s)
  Ibuki N, Inamoto T,Ichihashi A,Uehara H,Komura K,Hirano H,Nomi H,Azma H.
- Organizer
  AUA 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K16716
[Presentation] プラチナ抵抗性尿路上皮癌に対するPembrolizumabの治療効果予測因子の検討2019
- Author(s)
  伊夫貴　直和、稲元輝生、内本泰三、辻野拓也、南幸一郎、光野絢子、高木志寿子、木下将宏、徳永雄希、土井由紀子、中森啓太、木山賢、東治人.
- Organizer
  第107回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-18K16716
[Presentation] 当施設における腎細胞癌に対するpresurgical therapyの臨床的検討2019
- Author(s)
  伊夫貴　直和、稲元輝生、小村和正、上原博史、平野　一、能見勇人、東　治人.
- Organizer
  日本泌尿器腫瘍学会第5回学術集会
- Data Source
  KAKENHI-PROJECT-18K16716

1. INAMOTO Teruo

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
2. 東治人

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
3. 高原健

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ibuki Naokazu 伊夫貴 直和

Research Projects

Research Products

Co-Researchers

Elucidation of castration-resistant prostate cancer mechanism via hedgehog pathwayPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] hibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] 生体腎移植前のドナー検査において腫瘍性病変が指摘され、根治的治療が可能であった3症例2019

Author(s)

Organizer

Data Source

[Presentation] ハイリスクホルモン感受性転移性前立腺癌に対するAbiraterone acetateとPrednisolone併用療法の治療効果2019

Author(s)

Organizer

Data Source

[Presentation] Treatment outcome of dose reduction of enzalutamide against CRPC?2019

Author(s)

Organizer

Data Source

[Presentation] プラチナ抵抗性尿路上皮癌に対するPembrolizumabの治療効果予測因子の検討2019

Author(s)

Organizer

Data Source

[Presentation] 当施設における腎細胞癌に対するpresurgical therapyの臨床的検討2019

Author(s)

Organizer

Data Source

Ibuki Naokazu 伊夫貴直和